A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(35 sites)
United States
University of Alabama in Birmingham, Birmingham, Alabama University of California San Diego Medical Center, La Jolla, California Yale University School of Medicine, New Haven, Connecticut Emory University, Atlanta, Georgia Advocate Lutheran General Hospital, Park Ridge, Illinois Indiana University School of Medicine, Indianapolis, Indiana Washington University in St. Louis, St Louis, Missouri New York University Medical Center, New York, New York University of Pittsburgh, Pittsburgh, Pennsylvania Butler Hospital, Providence, Rhode Island Kerwin Research and Memory Center, Dallas, Texas University of Washington, Seattle, Washington Argentina
Instituto de Investigaciones Neurologicas Raul Carrea, FLENI, Ciudad Autonoma de Buenos Aire Australia
Neuroscience Research Australia, Randwick, New South Wales Alzheimer's Research Australia, Melbourne, Victoria Canada
UBC Hospital, Vancouver, British Columbia Sunnybrook Health Sciences Centre, Toronto, Ontario McGill Center for Studies in Aging, Verdun, Quebec CHU de Quebec - Hôpital de l' Enfant Jésus, Québec Colombia
Grupo de Neurociencias Sede de la Universidad de Antioquia, Medellín France
CHU de Toulouse - Hôpital Purpan, Toulouse, Haute Garonne Hopital Roger Salengro - CHU Lille, Lille, Nord Groupe Hospitalier Pitie-Salpetriere, Paris, Paris Hopital Neurologique Pierre Wertheimer, Bron, Rhone CHU de Rouen - Hôpital Charles Nicolle, Rouen, Seine Maritime Germany
Universitaetsklinikum Tubingen, Tübingen, Baden-Wurttemberg LMU-Campus Grosshadern, Munich, Bavaria Italy
IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia Azienda Ospedaliera Universitaria Careggi, Florence Mexico
Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico City Netherlands
Brain Research Center, Amsterdam New Zealand
New Zealand Brain Research Institute, Christchurch Puerto Rico
University of Puerto Rico, School of Medicine, San Juan Spain
Hospital Clínic I Provincial de Barcelona, Barcelona United Kingdom
The National Hospital for Neurology and Neurosurgery, London, Greater London Age range
18 Years and older
Last updated February 2026